Modulating macrophage activity via NAAA pharmacological inhibition: a therapeutic strategy for intestinal fibrosis

被引：0
|
作者：
Nani, M. [1 ]
De Cicco, P. [2 ]
Cattaneo, F. [3 ]
Petrosino, S. [4 ]
Tropeano, F. P. [5 ]
Miraglia, M. [2 ]
Pagano, E. [2 ]
Rinaldi, M. M. [2 ]
Izzo, A. A. [2 ]
Romano, B.
机构：
[1] Univ Naples Federico II, Dept Pharm, Naples, Italy
[2] Univ Naples Federico II, Sch Med & Surg, Dept Pharm, Naples, Italy
[3] Univ Naples Federico II, Sch Med & Surg, Dept Mol Med & Med Biotechnol, Naples, Italy
[4] CNR, Inst Biomol Chem, Pozzuoli, Italy
[5] Univ Naples Federico II, Sch Med & Surg, Dept Clin Med & Surg, Naples, Italy
来源：
JOURNAL OF CROHNS & COLITIS | 2025年 / 19卷
关键词：
D O I：
10.1093/ecco-jcc/jjae190.0355
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P0181
引用
收藏
页码：i580 / i580
页数：1
相关论文
共 50 条
  • [21] Inhibition of mTOR Mediates Alleviation of Intestinal Fibrosis via Suppression of Myofibroblast Proliferation
    Yang, Jun
    Cao, James
    Bartholomew, Catherine
    Zhu, Xinjun
    GASTROENTEROLOGY, 2013, 144 (05) : S813 - S813
  • [22] MAIT cell inhibition promotes liver fibrosis regression via macrophage phenotype reprogramming
    Morgane Mabire
    Pushpa Hegde
    Adel Hammoutene
    Jinghong Wan
    Charles Caër
    Rola Al Sayegh
    Mathilde Cadoux
    Manon Allaire
    Emmanuel Weiss
    Tristan Thibault-Sogorb
    Olivier Lantz
    Michèle Goodhardt
    Valérie Paradis
    Pierre de la Grange
    Hélène Gilgenkrantz
    Sophie Lotersztajn
    Nature Communications, 14
  • [23] MAIT cell inhibition promotes liver fibrosis regression via macrophage phenotype reprogramming
    Mabire, Morgane
    Hegde, Pushpa
    Hammoutene, Adel
    Wan, Jinghong
    Caer, Charles
    Al Sayegh, Rola
    Cadoux, Mathilde
    Allaire, Manon
    Weiss, Emmanuel
    Thibault-Sogorb, Tristan
    Lantz, Olivier
    Goodhardt, Michele
    Paradis, Valerie
    de la Grange, Pierre
    Gilgenkrantz, Helene
    Lotersztajn, Sophie
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [24] The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition
    Chang, Pamela V.
    Hao, Liming
    Offermanns, Stefan
    Medzhitov, Ruslan
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2014, 111 (06) : 2247 - 2252
  • [25] Pharmacological targeting macrophage phenotype via gut-kidney axis ameliorates renal fibrosis in mice
    Xie, Yanan
    Hu, Xiaofan
    Li, Shanglin
    Qiu, Yang
    Cao, Rui
    Xu, Cong
    Lu, Chenqi
    Wang, Zhimin
    Yang, Jun
    PHARMACOLOGICAL RESEARCH, 2022, 178
  • [26] Klotho is a novel therapeutic target in peritoneal fibrosis via Wnt signaling inhibition
    Kadoya, Hiroyuki
    Satoh, Minoru
    Nishi, Yuko
    Kondo, Megumi
    Wada, Yoshihisa
    Sogawa, Yuji
    Kidokoro, Kengo
    Nagasu, Hajime
    Sasaki, Tamaki
    Kashihara, Naoki
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 (05) : 773 - 781
  • [27] Moxibustion exhibits therapeutic effects on spinal cord injury via modulating microbiota dysbiosis and macrophage polarization
    Zhang, Zhuang
    Sui, Rubo
    Ge, Lili
    Xia, Dongjian
    AGING-US, 2022, 14 (14): : 5800 - 5811
  • [28] Pharmacological Inhibition of STAT6 Ameliorates Myeloid Fibroblast Activation and Alternative Macrophage Polarization in Renal Fibrosis
    Jiao, Baihai
    An, Changlong
    Tran, Melanie
    Du, Hao
    Wang, Penghua
    Zhou, Dong
    Wang, Yanlin
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [29] Podocyte histone deacetylase activity inhibition as a therapeutic strategy for glomerular disease
    Egerman, Marc A.
    Campbell, Kirk N.
    KIDNEY INTERNATIONAL, 2019, 96 (06) : 1266 - 1268
  • [30] Listeria monocytogenes membrane vesicles disrupting intestinal epithelial barrier function via modulating macrophage inflammatory responses
    Lei, Yao
    Chen, Kehan
    Tang, Mingyuan
    Zhang, Qiuyang
    Yu, Jie
    Zhang, Yunwen
    Tang, Tian
    Wang, Chuan
    INTERDISCIPLINARY MEDICINE, 2025,
12345